REPROCELL 产品代理

Stem Cell Reagents

Cells

Labware

Human Tissue Samples

REPROCELL's portfolio includes an extensive product catalog to support stem cell research and 3D bioengineered tissues, a commercial biorepository of ethically-sourced human tissues, extensive clinical networks across the US and Europe that enable our contract research services in human ex vivo living tissues, and our capability to supply induced pluripotent stem cells (iPSCs) for both research and clinical applications.

REPROCELL is also developing novel regenerative medicine therapies to treat neurodegenerative disease, based on its expertise in pluripotent stem cells and mesenchymal stem cells, and is currently conducting clinical trials in Japan for the treatment of spinocerebellar ataxia. Its diagnostic services and clinical research services are offered across labs in Japan, the US, UK, and India. Reprocell's expertise in patient recruitment, the logistics, and ethics of accessing human biospecimens and diagnostics is driving the development of new technologies to support biomarker research and precision medicine.  Combined with our clinical laboratory facilities, these resources and know-how have positioned REPROCELL as a fully integrated partner for the life sciences industry, with clients across the globe.

Few companies can claim to have such broad business activities and capabilities, making REPROCELL a unique partner for providing you with the services and materials you need to navigate the complex world of drug discovery and regenerative medicine.